NEW YORK (GenomeWeb) – Bio-Techne this week reported that its revenue for the second quarter rose 17 percent year over year to $154.2 million from $131.8 million, exceeding the average analyst estimate of $146.3 million.

Revenues from the firm's diagnostics business segment fell 4 percent to $23.4 million from $24.3 million in the prior-year quarter. Sales volume in the quarter was negatively affected by continued "push-outs” of orders by original equipment manufacturers "in a very cost-conscious diagnostics industry," the firm said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mice in New York harbor both antibiotic-resistant bacteria and novel viruses, according to a new analysis of their fecal microbiomes.

Human Heredity and Health in Africa Initiative has issued guidelines for genomic research in the region, according to Nature News.

The Associated Press reports that an ethicist predicts that prenatal diagnosis and other advances will lead to more choices being available to prospective parents.

In Genome Biology this week: approach to analyze alternative polyadenylation, algorithm to predict transcriptomic structural variations, and more.